XML 95 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity And Stock-Based Compensation
6 Months Ended
Mar. 27, 2020
Stockholders' Equity And Stock-Based Compensation [Abstract]  
Stockholders' Equity And Stock-Based Compensation Stockholders' Equity & Stock-Based Compensation
We provide stock-based awards as a form of compensation for employees, officers, and directors. We have issued stock-based awards in the form of stock options and restricted stock units ("RSUs") under our equity incentive plans, as well as shares under our ESPP.
Common Stock - Class A and Class B
Our Board of Directors has authorized two classes of common stock, Class A and Class B. At March 27, 2020, we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. At March 27, 2020, we had 64,422,131 shares of Class A common stock and 36,224,820 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation.
Stock Incentive Plans
2020 Stock Plan.    In January 2005, our stockholders approved our 2005 Stock Plan, which our Board of Directors adopted in November 2004. The 2005 Stock Plan became effective on February 16, 2005, the day prior to the completion of our initial public offering. In February 2020, our stockholders approved the name change of our 2005 Stock Plan to the 2020 Stock Plan and certain other changes described in our proxy statement for our 2020 annual meeting of stockholders. Our 2020 Stock Plan provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards, and performance shares. A total of 55.0 million shares of our Class A common stock have been authorized for issuance under the 2020 Stock Plan in total since inception of the plan. For awards granted prior to February 2011, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as two shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as two shares for every one share returned. For those awards granted from February 2011 onward, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as 1.6 shares for every one share returned.
Stock Options.    Stock options are granted at fair market value on the date of grant. Options granted to employees and officers prior to June 2008 generally vested over four years, with equal annual cliff-vesting and expire on the earlier of ten years after the date of grant or three months after termination of service. Options granted to employees and officers from June 2008 onward generally vest over four years, with 25% of the shares subject to the option becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months. These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2020 Stock Plan. Our 2020 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria.
Performance-Based Stock Options (PSOs).    In fiscal 2016, we began granting PSOs to our executive officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs is seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized TSR targets at the end of a three-year measurement period following the date of grant. If the minimum conditions are met, the PSOs earned will cliff vest on the third anniversary of the grant date, upon certification of achievement of the performance conditions by our Compensation Committee. Anywhere from 0% to 125% of the shares subject to a PSO may vest based on achievement of the performance conditions at the end of the three-year performance period.
In valuing the PSOs which will be recognized as compensation cost, we used a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-
performance based options granted under the 2020 Stock Plan. Compensation cost is being amortized on a straight-line basis over the requisite service period.
On December 15, 2018, we granted PSOs to our executive officers exercisable for an aggregate of 241,100 shares at the target award amount, which would be exercisable up to an aggregate of 301,375 shares at 125% of the target award amount. On December 15, 2017, we granted PSOs to our executive officers exercisable for an aggregate of 264,000 shares at the target award amount, which would be exercisable up to an aggregate of 330,000 shares at 125% of the target award amount. On December 15, 2016, we granted PSOs to our executive officers exercisable for an aggregate of 276,199 shares at the target award amount, which vested in December 2019 at 95% of the target award amount, for an aggregate of 240,539. On December 15, 2015, we granted PSOs to our executive officers, which vested in December 2018 at 125% of the target award amount, for an aggregate of 334,623 shares. As of March 27, 2020, PSOs which would be exercisable for an aggregate of 726,639 shares at the target award amount (1,032,673 at 125% of the target award amount) were outstanding.
Performance-Based Restricted Stock Units (PSUs).    In the first quarter of fiscal 2020, we began granting PSUs to our executive officers with shares of our Class A common stock underlying such awards. The terms of the PSU Agreement adopted in the first quarter fiscal 2020 provide for the grant of performance-based restricted stock units to our executive officers contingent on Dolby's achievement of annualized TSR targets measured against a comparator index over a three-year performance period following the date of grant. Anywhere from 0% to 200% of eligible restricted stock units may vest based on achievement of the performance conditions at the end of the three-year performance period. As of March 27, 2020, PSUs which would vest for an aggregate of 62,000 shares at the target amount (124,000 at 200% of the target award amount) were outstanding.
In valuing the PSUs which will be recognized as compensation cost, we used a Monte Carlo valuation model. Compensation cost is being amortized on a straight-line basis over the requisite service period.
The following table summarizes information about all stock options issued under our 2020 Stock Plan:
SharesWeighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Life
Aggregate
Intrinsic
Value (1)
 (in thousands) (in years)(in thousands)
Options outstanding at September 27, 20197,201  $48.03  
Grants1,099  67.87  
Exercises(1,164) 40.16  
Forfeitures and cancellations(77) 62.63  
Options outstanding at March 27, 20207,059  52.27  6.56$49,215  
Options vested and expected to vest at March 27, 20206,695  51.54  6.4649,181  
Options exercisable at March 27, 20204,119  $44.20  5.4247,209  
(1)Aggregate intrinsic value is based on the closing price of our Class A common stock on March 27, 2020 of $53.94 and excludes the impact of options that were not in-the-money.
Restricted Stock Units.    Beginning in fiscal 2008, we began granting RSUs to certain directors, officers, and employees under our 2020 Stock Plan. Awards granted to employees and officers generally vest over four years, with equal annual cliff-vesting. Awards granted to directors prior to November 2010 generally vested over three years, with equal annual cliff-vesting. Awards granted after November 2010 and prior to fiscal 2014 to new directors vested over approximately two years, with 50% vesting per year, while awards granted from November 2010 onward to ongoing directors generally vest over approximately one year. Awards granted to new directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. Our 2020 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria, although no such awards had been granted as of March 27, 2020. At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the fair market value of our Class A common stock on the date of grant and is recognized on a straight-line basis over the requisite service period.
The following table summarizes information about RSUs issued under our 2020 Stock Plan:
SharesWeighted-Average
Grant Date
Fair Value 
 (in thousands)
Non-vested at September 27, 20192,805  $58.84  
Granted1,296  66.22  
Vested(969) 52.21  
Forfeitures(84) 60.35  
Non-vested at March 27, 20203,048  $62.59  
Employee Stock Purchase Plan.   Our plan allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six-month purchase periods, with a look back feature to our stock price at the commencement of a one-year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the New York Stock Exchange on the first and last day of the offering periods. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period.
Stock Option Valuation Assumptions
We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the future risk-free interest rate, and the volatility of our stock price over the expected term of the award.
Expected Term.    The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior.
Risk-Free Interest Rate.    The risk-free interest rate is based on the yield curve of United States Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards.
Expected Stock Price Volatility.    The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards, and is determined using a blended combination of historical and implied volatility. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock.
Dividend Yield.    The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time.
The weighted-average assumptions used in the determination of the fair value of our stock options were as follows:
 Fiscal Quarter EndedFiscal Year-To-Date Ended
 March 27,
2020
March 29,
2019
March 27,
2020
March 29,
2019
Expected life (in years)4.910.004.914.90
Risk-free interest rate0.6 %— %1.7 %2.7 %
Expected stock price volatility25.8 %— %24.0 %22.9 %
Dividend yield1.3 %— %1.3 %1.1 %
Stock-Based Compensation Expense
Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly.
The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands):
Expense - By Award Type
 Fiscal Quarter EndedFiscal Year-To-Date Ended
 March 27,
2020
March 29,
2019
March 27,
2020
March 29,
2019
Compensation expense - by type
Stock options$3,974  $4,279  $8,520  $9,301  
Restricted stock units15,850  13,895  32,817  29,270  
Employee stock purchase plan1,127  1,061  2,228  2,146  
Total stock-based compensation20,951  19,235  43,565  40,717  
Benefit from income taxes(3,521) (3,465) (7,115) (7,225) 
Total stock-based compensation, net of tax$17,430  $15,770  $36,450  $33,492  

Expense - By Income Statement Line Item Classification
 Fiscal Quarter EndedFiscal Year-To-Date Ended
 March 27,
2020
March 29,
2019
March 27,
2020
March 29,
2019
Compensation expense - by classification
Cost of products and services$507  $412  $1,050  $900  
Research and development6,179  5,785  13,166  12,026  
Sales and marketing7,702  7,217  $15,876  $15,434  
General and administrative6,563  5,821  13,473  12,357  
Total stock-based compensation expense20,951  19,235  43,565  40,717  
Benefit from income taxes(3,521) (3,465) (7,115) (7,225) 
Total stock-based compensation, net of tax$17,430  $15,770  $36,450  $33,492  
The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. This benefit was as follows (in thousands):
 Fiscal Quarter EndedFiscal Year-To-Date Ended
 March 27,
2020
March 29,
2019
March 27,
2020
March 29,
2019
Tax benefit - shares issued under ESPP$50  $59  $252  $201  
Unrecognized Compensation Expense.    At March 27, 2020, total unrecorded compensation expense associated with employee stock options expected to vest was approximately $29.9 million, which is expected to be recognized over a weighted-average period of 2.5 years. At March 27, 2020, total unrecorded compensation expense associated with RSUs expected to vest was approximately $146.4 million, which is expected to be recognized over a weighted-average period of 2.8 years.
Common Stock Repurchase Program
In November 2009, we announced a stock repurchase program ("program"), providing for the repurchase of up to $250.0 million of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of March 27, 2020 (in thousands):
Authorization PeriodAuthorization Amount
Fiscal 2010: November 2009$250,000  
Fiscal 2010: July 2010300,000  
Fiscal 2011: July 2011250,000  
Fiscal 2012: February 2012100,000  
Fiscal 2015: October 2014200,000  
Fiscal 2017: January 2017200,000  
Fiscal 2018: July 2018350,000  
Fiscal 2019: July 2019350,000  
Total  $2,000,000  
Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock. As of March 27, 2020, the remaining authorization to purchase additional shares is approximately $259 million.
The following table provides information regarding share repurchase activity under the program during fiscal 2020:
Quarterly Repurchase ActivityShares
Repurchased
Cost in thousands (1)
Average Price Paid Per Share (2)
Q1 - Quarter ended December 27, 2019  432,042  $30,003  $69.44  
Q2 - Quarter ended March 27, 2020  1,015,481  71,669  70.57  
Total1,447,523  $101,672  
(1)Cost of share repurchases includes the price paid per share and applicable commissions.
(2)Average price paid per share excludes commission costs.
Dividend Program
The following table summarizes dividends declared under the program in relation to fiscal 2020:
Fiscal PeriodAnnouncement DateRecord DatePayment DateCash Dividend Per Common ShareDividend Payment
Fiscal 2020
Q1 - Quarter ended December 27, 2019January 29, 2020February 10, 2020February 20, 2020$0.22  $22.2 million
Q2 - Quarter ended March 27, 2020May 4, 2020May 18, 2020May 27, 2020$0.22  $22.1 million(1)
(1)The amount of the dividend payment is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.